Ramhari Kumbhar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ramhari Kumbhar has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Ted Murray Dawson
NeuroRegeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, USA
5 shared publications - Xiaobo Mao
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
5 shared publications - Kundlik Gadhave
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology, Johns Hopkins University School of Medicine
4 shared publications Lingtao Jin
Department of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
4 shared publicationsMingyao Ying
Section of Genetic Medicine, Department of Medicine, Biological Sciences Division, University of Chicago
4 shared publicationsShu Zhang
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Department of Neurology, Johns Hopkins University School of Medicine
4 shared publications
Latest Publications
- Open Access
- 14 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Targeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras
α-Synucleinopathies are devastating neurodegenerative diseases characterized by pathological accumulation of a neuronal protein, α-synuclein (αSyn). Lowering soluble αSyn levels is a promising therapeutic strategy to limit aggregation and neurotoxicity, but directly targeting this protein is hindered by its intrinsically disordered structure and other factors, such as its conformational heterogeneity and intracellular drug delivery barriers. Consequently, increasing attention has been directed toward targeting the SNCA transcript, which encodes αSyn. Here, we developed phosphorodiamidate morpholino oligonucleotide (PMO)-based RNA-degrading chimeras (RDCs) that selectively bind the 5′ untranslated region of SNCA messenger RNA (mRNA) and recruit RNase L for targeted RNA degradation. Through the systematic evaluation of nine RDCs, we identified and optimized 4-D1, which effectively reduced SNCA mRNA and αSyn protein expression in HEK293T cells in an RNase L-dependent manner. 4-D1 lowered SNCA transcript and αSyn protein levels in both primary cortical neurons from humanized SNCA mice and in human induced pluripotent stem cell–derived cortical neurons. This reduction prevented prion-like seeding induced by patient-derived αSyn fibrils and protected neurons from fibril-induced cytotoxicity. Finally, in vivo studies confirmed the efficacy of 4-D1 in reducing αSyn mRNA expression in humanized SNCA mice. These findings indicate that PMO-based RDCs may represent a promising therapeutic modality for α-synucleinopathies.
- 14 July 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (29)
Open AccessTargeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras
α-Synucleinopathies are devastating neurodegenerative diseases characterized by pathological accumulation of a neuronal protein, α-synuclein (αSyn). Lowering soluble αSyn levels is a promising therapeutic strategy to limit aggregation and neurotoxicity, but directly targeting this protein is hindered by its intrinsically disordered structure and other factors, such as its conformational heterogeneity and intracellular drug delivery barriers. Consequently, increasing attention has been directed toward targeting the SNCA transcript, which encodes αSyn. Here, we developed phosphorodiamidate morpholino oligonucleotide (PMO)-based RNA-degrading chimeras (RDCs) that selectively bind the 5′ untranslated region of SNCA messenger RNA (mRNA) and recruit RNase L for targeted RNA degradation. Through the systematic evaluation of nine RDCs, we identified and optimized 4-D1, which effectively reduced SNCA mRNA and αSyn protein expression in HEK293T cells in an RNase L-dependent manner. 4-D1 lowered SNCA transcript and αSyn protein levels in both primary cortical neurons from humanized SNCA mice and in human induced pluripotent stem cell–derived cortical neurons. This reduction prevented prion-like seeding induced by patient-derived αSyn fibrils and protected neurons from fibril-induced cytotoxicity. Finally, in vivo studies confirmed the efficacy of 4-D1 in reducing αSyn mRNA expression in humanized SNCA mice. These findings indicate that PMO-based RDCs may represent a promising therapeutic modality for α-synucleinopathies.
- 1 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Mechanism of ubiquitylation in DNA damage response
Mécanismes d'ubiquitylation dans la réponse aux dommages de l'ADN: L’ubiquitylation est une modification post-transcriptionelle qui est nécessaire pour la dégradation des protéines mais aussi pour la régulation et la localisation de nombreux facteurs. Un grand nombre de protéines impliquées dans la réplication de l’ADN et dans la réponse aux lésions de l’ADN sont ubiquitylées. L’ubiquitylation durant la réponse aux dommages de l’ADN dépend de l’enzyme d’activation de l’ubiquitine UBA1 qui est située au sommet de la cascade d’ubiquitination. Durant ma thèse, j’ai mis à jour le mécanisme de recrutement d’UBA1 au niveau de l’ADN endommagé ainsi qu’un rôle majeur de l’ubiquitylation dans la voie de signalisation ATR.A l’aide d’une approche in vitro qui mime la voie de signalisation ATR, j’ai montré qu’UBA1 est recrutée au niveau de molécules d’ADN linéaire et qu’elle est nécessaire à l’ubiquitylation des protéines recrutées sur ce substrat. J’ai également découvert que l’ubiquitylation et le recrutement d’UBA1 in vitro sont dépendants de la kinase DNA-PKcs et de la poly(ADP-ribose) polymérase PARP1, deux senseurs majeurs des lésions de l’ADN. Il apparait que PARP1 régule le recrutement d’UBA1 via la formation de chaines de poly(ADP)-ribose (PAR). De plus, j’ai montré qu’UBA1 est capable de se lier aux chaines PAR. J’ai identifié la région d’UBA1 capable d’interagir avec les chaines PAR : il apparait que cette région est désorganisée et riche en acide aminés hydrophobes. La comparaison de la protéine UBA1 de levure et la protéine UBA6 humaine qui ne lient pas PAR nous a permis d’identifier les acides aminées hydrophobes nécessaires pour la lésion à PAR.J’ai aussi démontré qu’UBA1 est nécessaire pour la réponse aux lésions de l’ADN. En effet, l’inhibition ou la déplétion d’UBA1 conduit à une perte de la phosphorylation de Chk1 dans notre système in vitro. De même, le traitement avec des molécules induisant des lésions de l’ADN telles que le CPT, le MMS et la bléocine conduit à une phosphorylation moindre de Chk1 lorsqu’UBA1 est inhibée. Afin de démontrer que la liaison d’UBA1 aux chaines PAR est cruciale pour la réponse aux dommages, j’ai mis en place un système in vivo permettant d’exprimer des mutants d’UBA1 incapable de lier les chaines PAR.Globalement mes résultats indiquent qu’UBA1 est recrutée au niveau de l’ADN endommagé à l’aide de PARP1 et DNA-PKcs. Plus précisément, il apparait que la liaison avec les chaines PAR et l’ubiquitylation de protéines spécifiques est nécessaire pour la mise en place de la voie de signalisation ATR. L’importance d’UBA1 dans le processus est soulignée par le fait que son inhibition ou son inactivation conduit à une phosphorylation moindre de Chk1. Il est raisonnable de penser que des inhibiteurs d’UBA1 puissent être utilisés pour cibler la voie ATR dans les cellules cancéreuses. Finalement, cette étude devrait permettre de mieux comprendre comment les interactions entre les processus d’ubiquitylation et de PARylation permettent de réguler la réponse aux dommages.
- 1 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Mechanism of ubiquitylation in DNA damage response
Mécanismes d'ubiquitylation dans la réponse aux dommages de l'ADN: L’ubiquitylation est une modification post-transcriptionelle qui est nécessaire pour la dégradation des protéines mais aussi pour la régulation et la localisation de nombreux facteurs. Un grand nombre de protéines impliquées dans la réplication de l’ADN et dans la réponse aux lésions de l’ADN sont ubiquitylées. L’ubiquitylation durant la réponse aux dommages de l’ADN dépend de l’enzyme d’activation de l’ubiquitine UBA1 qui est située au sommet de la cascade d’ubiquitination. Durant ma thèse, j’ai mis à jour le mécanisme de recrutement d’UBA1 au niveau de l’ADN endommagé ainsi qu’un rôle majeur de l’ubiquitylation dans la voie de signalisation ATR.A l’aide d’une approche in vitro qui mime la voie de signalisation ATR, j’ai montré qu’UBA1 est recrutée au niveau de molécules d’ADN linéaire et qu’elle est nécessaire à l’ubiquitylation des protéines recrutées sur ce substrat. J’ai également découvert que l’ubiquitylation et le recrutement d’UBA1 in vitro sont dépendants de la kinase DNA-PKcs et de la poly(ADP-ribose) polymérase PARP1, deux senseurs majeurs des lésions de l’ADN. Il apparait que PARP1 régule le recrutement d’UBA1 via la formation de chaines de poly(ADP)-ribose (PAR). De plus, j’ai montré qu’UBA1 est capable de se lier aux chaines PAR. J’ai identifié la région d’UBA1 capable d’interagir avec les chaines PAR : il apparait que cette région est désorganisée et riche en acide aminés hydrophobes. La comparaison de la protéine UBA1 de levure et la protéine UBA6 humaine qui ne lient pas PAR nous a permis d’identifier les acides aminées hydrophobes nécessaires pour la lésion à PAR.J’ai aussi démontré qu’UBA1 est nécessaire pour la réponse aux lésions de l’ADN. En effet, l’inhibition ou la déplétion d’UBA1 conduit à une perte de la phosphorylation de Chk1 dans notre système in vitro. De même, le traitement avec des molécules induisant des lésions de l’ADN telles que le CPT, le MMS et la bléocine conduit à une phosphorylation moindre de Chk1 lorsqu’UBA1 est inhibée. Afin de démontrer que la liaison d’UBA1 aux chaines PAR est cruciale pour la réponse aux dommages, j’ai mis en place un système in vivo permettant d’exprimer des mutants d’UBA1 incapable de lier les chaines PAR.Globalement mes résultats indiquent qu’UBA1 est recrutée au niveau de l’ADN endommagé à l’aide de PARP1 et DNA-PKcs. Plus précisément, il apparait que la liaison avec les chaines PAR et l’ubiquitylation de protéines spécifiques est nécessaire pour la mise en place de la voie de signalisation ATR. L’importance d’UBA1 dans le processus est soulignée par le fait que son inhibition ou son inactivation conduit à une phosphorylation moindre de Chk1. Il est raisonnable de penser que des inhibiteurs d’UBA1 puissent être utilisés pour cibler la voie ATR dans les cellules cancéreuses. Finalement, cette étude devrait permettre de mieux comprendre comment les interactions entre les processus d’ubiquitylation et de PARylation permettent de réguler la réponse aux dommages.
- Top Cited Papers
- 4 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6764) , eadu4132
Lewy body dementia promotion by air pollutants
Evidence links air pollution to dementia, yet its role in Lewy body dementia (LBD) remains unclear. In this work, we showed in a cohort of 56.5 million individuals across the United States that fine particulate matter (PM 2.5 ) exposure raises LBD risk. Mechanistically, we found that PM 2.5 exposure led to brain atrophy in wild-type mice, an effect not seen in α-synuclein (αSyn)–deficient mice. PM 2.5 exposure generated a highly pathogenic αSyn strain, PM 2.5 –induced preformed fibril (PM-PFF), with enhanced proteinase K resistance and neurotoxicity, resembling αSyn LBD strains. PM 2.5 samples from China, the United States, and Europe consistently induced proteinase-resistant αSyn strains and in vivo pathology. Transcriptomic analyses revealed shared responses between PM 2.5 -exposed mice and LBD patients, underscoring PM 2.5 ’s role in LBD and stressing the need for interventions to reduce air pollution and its associated neurological disease burden.
- 4 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6764) , eadu4132
Top Cited PapersLewy body dementia promotion by air pollutants
Evidence links air pollution to dementia, yet its role in Lewy body dementia (LBD) remains unclear. In this work, we showed in a cohort of 56.5 million individuals across the United States that fine particulate matter (PM 2.5 ) exposure raises LBD risk. Mechanistically, we found that PM 2.5 exposure led to brain atrophy in wild-type mice, an effect not seen in α-synuclein (αSyn)–deficient mice. PM 2.5 exposure generated a highly pathogenic αSyn strain, PM 2.5 –induced preformed fibril (PM-PFF), with enhanced proteinase K resistance and neurotoxicity, resembling αSyn LBD strains. PM 2.5 samples from China, the United States, and Europe consistently induced proteinase-resistant αSyn strains and in vivo pathology. Transcriptomic analyses revealed shared responses between PM 2.5 -exposed mice and LBD patients, underscoring PM 2.5 ’s role in LBD and stressing the need for interventions to reduce air pollution and its associated neurological disease burden.
- Open Access
α-Synuclein strain dynamics predict cognitive transitions in Parkinson’s disease
α-Synuclein (α-syn) strains can serve as discriminators between Parkinson’s disease (PD) and related α-synucleinopathies. The relationship between α-syn strain dynamics and clinical performance as patients transition from normal cognition (NC) to cognitive impairment (CI) is not known. Here, we show that the biophysical properties and neurotoxicity of α-syn strains change as PD cognitive status transitions from NC to mild cognitive impairment (PD-MCI) and dementia (PD-D). Both cross-sectional and longitudinal analyses reveal distinct α-syn strains in PD patients correlating to their level of cognitive impairment. Machine learning (ML) was employed to achieve high classification accuracy. The combination of thioflavin T (ThT) maximal fluorescence intensity (mfi), max slope of rise curve (forming rate), lag time (t lag ), 20% time (t 20 ), and half-time (t 50 ), dynamic light scattering (DLS) (peak number, ½ peak size, ½ peak intensity) and neurotoxicity together with demographic variables for model training yielded superior performance (89∼99% accuracy in the 4- and 2- classification schema) compared to individual features alone in classifying cognitive status. For the longitudinal study, DLS peak number emerged as the strongest predictor of cognitive transition (HR = 0.12, P = 0.002), with the optimal predictive model combining DLS peak number, sex, education, DLS peak 1 size, and DLS peak 2 polydispersity achieving high accuracy (C-index of ∼93%). This study presents evidence that individuals with PD have different α-syn strains correlating to their cognitive status and highlights the potential of α-syn strain dynamics to guide future diagnosis, management, and stratification of PD patients. One Sentence Summary: Distinct features of α-syn strains change with cognitive decline in Parkinson’s disease and AI-based analysis incorporating these combined characteristics serves as a powerful tool for PD clinical stratification.
Open Accessα-Synuclein strain dynamics predict cognitive transitions in Parkinson’s disease
α-Synuclein (α-syn) strains can serve as discriminators between Parkinson’s disease (PD) and related α-synucleinopathies. The relationship between α-syn strain dynamics and clinical performance as patients transition from normal cognition (NC) to cognitive impairment (CI) is not known. Here, we show that the biophysical properties and neurotoxicity of α-syn strains change as PD cognitive status transitions from NC to mild cognitive impairment (PD-MCI) and dementia (PD-D). Both cross-sectional and longitudinal analyses reveal distinct α-syn strains in PD patients correlating to their level of cognitive impairment. Machine learning (ML) was employed to achieve high classification accuracy. The combination of thioflavin T (ThT) maximal fluorescence intensity (mfi), max slope of rise curve (forming rate), lag time (t lag ), 20% time (t 20 ), and half-time (t 50 ), dynamic light scattering (DLS) (peak number, ½ peak size, ½ peak intensity) and neurotoxicity together with demographic variables for model training yielded superior performance (89∼99% accuracy in the 4- and 2- classification schema) compared to individual features alone in classifying cognitive status. For the longitudinal study, DLS peak number emerged as the strongest predictor of cognitive transition (HR = 0.12, P = 0.002), with the optimal predictive model combining DLS peak number, sex, education, DLS peak 1 size, and DLS peak 2 polydispersity achieving high accuracy (C-index of ∼93%). This study presents evidence that individuals with PD have different α-syn strains correlating to their cognitive status and highlights the potential of α-syn strain dynamics to guide future diagnosis, management, and stratification of PD patients. One Sentence Summary: Distinct features of α-syn strains change with cognitive decline in Parkinson’s disease and AI-based analysis incorporating these combined characteristics serves as a powerful tool for PD clinical stratification.
- Open Access
- 7 February 2024
- Published by Wiley in Advanced Science
- Vol. 11 (16) , e2303775
Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission
The spread of prion‐like protein aggregates is a common driver of pathogenesis in various neurodegenerative diseases, including Alzheimer's disease (AD) and related Tauopathies. Tau pathologies exhibit a clear progressive spreading pattern that correlates with disease severity. Clinical observation combined with complementary experimental studies has shown that Tau preformed fibrils (PFF) are prion‐like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several cell surface receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remain poorly understood. Here, it is shown that the lymphocyte‐activation gene 3 (Lag3) is a cell surface receptor that binds to PFF but not the monomer of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron‐to‐neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. These results identify neuronal Lag3 as a receptor of pathologic Tau in the brain,and for AD and related Tauopathies, a therapeutic target.
- 7 February 2024
- Published by Wiley in Advanced Science
- Vol. 11 (16) , e2303775
Open AccessLymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission
The spread of prion‐like protein aggregates is a common driver of pathogenesis in various neurodegenerative diseases, including Alzheimer's disease (AD) and related Tauopathies. Tau pathologies exhibit a clear progressive spreading pattern that correlates with disease severity. Clinical observation combined with complementary experimental studies has shown that Tau preformed fibrils (PFF) are prion‐like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several cell surface receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remain poorly understood. Here, it is shown that the lymphocyte‐activation gene 3 (Lag3) is a cell surface receptor that binds to PFF but not the monomer of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron‐to‐neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. These results identify neuronal Lag3 as a receptor of pathologic Tau in the brain,and for AD and related Tauopathies, a therapeutic target.
- Open Access
Pathological Tau transmission initiated by binding lymphocyte-activation gene 3
The spread of prion-like protein aggregates is believed to be a common driver of pathogenesis in many neurodegenerative diseases. Accumulated tangles of filamentous Tau protein are considered pathogenic lesions of Alzheimer’s disease (AD) and related Tauopathies, including progressive supranuclear palsy, and corticobasal degeneration. Tau pathologies in these illnesses exhibits a clear progressive and hierarchical spreading pattern that correlates with disease severity 1, 2 . Clinical observation combined with complementary experimental studies 3, 4 have shown that Tau preformed fibrils (PFF) are prion-like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remains poorly understood. Here, we show that the lymphocyte-activation gene 3 (Lag3) is a cell surface receptor that binds to PFF, but not monomer, of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron-to-neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. Our results identify neuronal Lag3 as a receptor of pathologic Tau in the brain, and for AD and related Tauopathies a therapeutic target. One Sentence Summary: Lag3 is a neuronal receptor specific for Tau PFF, and is required for uptake, propagation and transmission of Tau pathology.
Open AccessPathological Tau transmission initiated by binding lymphocyte-activation gene 3
The spread of prion-like protein aggregates is believed to be a common driver of pathogenesis in many neurodegenerative diseases. Accumulated tangles of filamentous Tau protein are considered pathogenic lesions of Alzheimer’s disease (AD) and related Tauopathies, including progressive supranuclear palsy, and corticobasal degeneration. Tau pathologies in these illnesses exhibits a clear progressive and hierarchical spreading pattern that correlates with disease severity 1, 2 . Clinical observation combined with complementary experimental studies 3, 4 have shown that Tau preformed fibrils (PFF) are prion-like seeds that propagate pathology by entering cells and templating misfolding and aggregation of endogenous Tau. While several receptors of Tau are known, they are not specific to the fibrillar form of Tau. Moreover, the underlying cellular mechanisms of Tau PFF spreading remains poorly understood. Here, we show that the lymphocyte-activation gene 3 (Lag3) is a cell surface receptor that binds to PFF, but not monomer, of Tau. Deletion of Lag3 or inhibition of Lag3 in primary cortical neurons significantly reduces the internalization of Tau PFF and subsequent Tau propagation and neuron-to-neuron transmission. Propagation of Tau pathology and behavioral deficits induced by injection of Tau PFF in the hippocampus and overlying cortex are attenuated in mice lacking Lag3 selectively in neurons. Our results identify neuronal Lag3 as a receptor of pathologic Tau in the brain, and for AD and related Tauopathies a therapeutic target. One Sentence Summary: Lag3 is a neuronal receptor specific for Tau PFF, and is required for uptake, propagation and transmission of Tau pathology.
- Open Access
- 18 May 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (7)
Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
The histone demethylase KDM5A erases histone H3 lysine 4 methylation, which is involved in transcription and DNA damage responses (DDRs). While DDR functions of KDM5A have been identified, how KDM5A recognizes DNA lesion sites within chromatin is unknown. Here, we identify two factors that act upstream of KDM5A to promote its association with DNA damage sites. We have identified a noncanonical poly(ADP-ribose) (PAR)–binding region unique to KDM5A. Loss of the PAR-binding region or treatment with PAR polymerase (PARP) inhibitors (PARPi’s) blocks KDM5A–PAR interactions and DNA repair functions of KDM5A. The histone variant macroH2A1.2 is also specifically required for KDM5A recruitment and function at DNA damage sites, including homology-directed repair of DNA double-strand breaks and repression of transcription at DNA breaks. Overall, this work reveals the importance of PAR binding and macroH2A1.2 in KDM5A recognition of DNA lesion sites that drive transcriptional and repair activities at DNA breaks within chromatin that are essential for maintaining genome integrity.
- 18 May 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (7)
Open AccessPoly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
The histone demethylase KDM5A erases histone H3 lysine 4 methylation, which is involved in transcription and DNA damage responses (DDRs). While DDR functions of KDM5A have been identified, how KDM5A recognizes DNA lesion sites within chromatin is unknown. Here, we identify two factors that act upstream of KDM5A to promote its association with DNA damage sites. We have identified a noncanonical poly(ADP-ribose) (PAR)–binding region unique to KDM5A. Loss of the PAR-binding region or treatment with PAR polymerase (PARP) inhibitors (PARPi’s) blocks KDM5A–PAR interactions and DNA repair functions of KDM5A. The histone variant macroH2A1.2 is also specifically required for KDM5A recruitment and function at DNA damage sites, including homology-directed repair of DNA double-strand breaks and repression of transcription at DNA breaks. Overall, this work reveals the importance of PAR binding and macroH2A1.2 in KDM5A recognition of DNA lesion sites that drive transcriptional and repair activities at DNA breaks within chromatin that are essential for maintaining genome integrity.
- Open Access
Poly(ADP-ribose)-binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
The histone demethylase KDM5A removes histone H3 lysine 4 methylation, which is involved in transcription and DNA damage responses (DDR). While DDR functions of KDM5A have been identified, how KDM5A recognizes DNA lesion sites within chromatin is unknown. Here, we identify two factors that act upstream of KDM5A to promote its association with DNA damage sites. We have identified a non-canonical poly(ADP-ribose), (PAR), binding region unique to KDM5A. Loss of the PAR-binding region or treatment with PAR polymerase (PARP) inhibitors (PARPi) blocks KDM5A-PAR interactions and DNA repair functions of KDM5A. The histone variant macroH2A1.2 is also specifically required for KDM5A recruitment and functions at DNA damage sites, including homology-directed repair of DNA double-strand breaks and repression of transcription at DNA breaks. Overall, this work reveals the importance of PAR-binding and macroH2A1.2 in KDM5A recognition of damage sites that drive transcriptional and repair activities at DNA breaks within chromatin that are essential for maintaining genome integrity. Summary: The histone demethylase KDM5A demethylates H3K4 to promote repair and transcriptional responses at DNA breaks. We identified poly(ADP-ribose)-binding and macroH2A1.2 as modulators of KDM5A association with DNA damage sites, revealing how KDM5A engages DNA breaks within chromatin.
Open AccessPoly(ADP-ribose)-binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
The histone demethylase KDM5A removes histone H3 lysine 4 methylation, which is involved in transcription and DNA damage responses (DDR). While DDR functions of KDM5A have been identified, how KDM5A recognizes DNA lesion sites within chromatin is unknown. Here, we identify two factors that act upstream of KDM5A to promote its association with DNA damage sites. We have identified a non-canonical poly(ADP-ribose), (PAR), binding region unique to KDM5A. Loss of the PAR-binding region or treatment with PAR polymerase (PARP) inhibitors (PARPi) blocks KDM5A-PAR interactions and DNA repair functions of KDM5A. The histone variant macroH2A1.2 is also specifically required for KDM5A recruitment and functions at DNA damage sites, including homology-directed repair of DNA double-strand breaks and repression of transcription at DNA breaks. Overall, this work reveals the importance of PAR-binding and macroH2A1.2 in KDM5A recognition of damage sites that drive transcriptional and repair activities at DNA breaks within chromatin that are essential for maintaining genome integrity. Summary: The histone demethylase KDM5A demethylates H3K4 to promote repair and transcriptional responses at DNA breaks. We identified poly(ADP-ribose)-binding and macroH2A1.2 as modulators of KDM5A association with DNA damage sites, revealing how KDM5A engages DNA breaks within chromatin.
- 25 May 2019
- Published by Springer Nature
- Vol. 1999, 61-74
In Time and Space: Laser Microirradiation and the DNA Damage Response
Maintenance of genomic integrity depends on the spatiotemporal recruitment and regulation of DNA damage response and repair proteins at DNA damage sites. These highly dynamic processes have been widely studied using laser microirradiation coupled with fluorescence microscopy. Laser microirradiation has provided a powerful methodology to identify and determine mechanisms of DNA damage response pathways. Here we describe methods used to analyze protein recruitment dynamics of fluorescently tagged or endogenous proteins to laser-induced DNA damage sites using laser scanning and fluorescence microscopy. We further describe multiple applications employing these techniques to study additional processes at DNA damage sites including transcription. Together, we aim to provide robust visualization methods employing laser-microirradiation to detect and determine protein behavior, functions and dynamics in response to DNA damage in mammalian cells.
- 25 May 2019
- Published by Springer Nature
- Vol. 1999, 61-74
In Time and Space: Laser Microirradiation and the DNA Damage Response
Maintenance of genomic integrity depends on the spatiotemporal recruitment and regulation of DNA damage response and repair proteins at DNA damage sites. These highly dynamic processes have been widely studied using laser microirradiation coupled with fluorescence microscopy. Laser microirradiation has provided a powerful methodology to identify and determine mechanisms of DNA damage response pathways. Here we describe methods used to analyze protein recruitment dynamics of fluorescently tagged or endogenous proteins to laser-induced DNA damage sites using laser scanning and fluorescence microscopy. We further describe multiple applications employing these techniques to study additional processes at DNA damage sites including transcription. Together, we aim to provide robust visualization methods employing laser-microirradiation to detect and determine protein behavior, functions and dynamics in response to DNA damage in mammalian cells.